EX-FILING FEES
S-8 S-8 EX-FILING FEES 0001400118 Sagimet Biosciences Inc. N/A Fees to be Paid Fees to be Paid 0001400118 2026-03-10 2026-03-10 0001400118 1 2026-03-10 2026-03-10 0001400118 2 2026-03-10 2026-03-10 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-8

Sagimet Biosciences Inc.

Table 1: Newly Registered Securities

Security Type

Security Class Title

Fee Calculation Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

1 Equity Series A Common Stock, par value $0.0001 457(a) 1,278,164 $ 5.41 $ 6,914,867.24 0.0001381 $ 954.94
2 Equity Series A Common Stock, par value $0.0001 457(a) 215,497 $ 5.41 $ 1,165,838.77 0.0001381 $ 161.00

Total Offering Amounts:

$ 8,080,706.01

$ 1,115.94

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 1,115.94

Offering Note

1

Note 1a. Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers an indeterminate number of additional shares of common stock, par value $0.0001 (the "Common Stock") of Sagimet Biosciences Inc. (the "Registrant") issuable under the Sagimet Biosciences Inc. 2023 Stock Option and Incentive Plan (the "2023 Plan") and the Sagimet Biosciences Inc. Amended and Restated 2023 Employee Stock Purchase Plan (the "2023 ESPP") in the event the number of outstanding shares of the Registrant is increased by reason of any stock dividend, stock split, recapitalization, merger, consolidation or reorganization or similar transaction. Note 1b. Represents 1,278,164 shares of Common Stock that were added to the shares authorized for issuance under the 2023 Plan on January 1, 2026 pursuant to an "evergreen" provision contained in the 2023 Plan. Note 1c. Represents 215,497 shares of Common Stock that were added to the shares authorized for issuance under the 2023 ESPP on January 1, 2026 pursuant to an "evergreen" provision contained in the 2023 ESPP. Note 1d. This estimate is made pursuant to Rule 457(h) and Rule 457(c) of the Securities Act. The price shown is based upon the average of the high and low prices reported for the Common Stock on the Nasdaq Global Select Market on March 6, 2026. Note 1e. The Registrant does not have any fee offsets.

2

See Note 1a. See Note 1b. See Note 1c. See Note 1d. See Note 1e.
Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Security Type Associated with Fee Offset Claimed Security Title Associated with Fee Offset Claimed Unsold Securities Associated with Fee Offset Claimed Unsold Aggregate Offering Amount Associated with Fee Offset Claimed Fee Paid with Fee Offset Source
Rule 457(p)
Fee Offset Claims N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Fee Offset Sources N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A